Trial intelligence / Profile preview

GIMIAS Validation for Left Atrium Fibrosis Detection

NCT02274246Phase 1Completed

Sponsor
Fundació Clínic per a la Recerca Biomèdica
Start
Nov 2014
Primary completion
Mar 2015
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Proportion of subjects with contrast enhancement in left atrium. Started Nov 2014; status: completed.

Beyond the preview

Go deeper on NCT02274246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02274246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call